Thomas Cerny
Pleura mesothelioma: combined modality treatments
Cerny T, Giaccone G. Pleura mesothelioma: combined modality treatments. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002; 13 Suppl 4:217-25.
01.01.2002Pleura mesothelioma: combined modality treatments
01.01.2002Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002; 13 Suppl 4:217-25
Cerny Thomas, Giaccone G
Massive Leberverkalkung und verkalkte Weichteilmetastasen bei kolorektalem Carcinom
Diethelm M, Kluckert J, Cerny T. Massive Leberverkalkung und verkalkte Weichteilmetastasen bei kolorektalem Carcinom. Swiss Medical Forum 2002; 10:241-242.
01.01.2002Massive Leberverkalkung und verkalkte Weichteilmetastasen bei kolorektalem Carcinom
01.01.2002Swiss Medical Forum 2002; 10:241-242
Diethelm Markus, Kluckert Jörg-Thomas, Cerny Thomas
Elevated carbohydrate antigen 19-9 (CA 19-9) in patients with Echinococcus infection
Pfister M, Gottstein B, Kretschmer R, Cerny T. Elevated carbohydrate antigen 19-9 (CA 19-9) in patients with Echinococcus infection. Clinical chemistry and laboratory medicine : CCLM / FESCC 2001; 39:527-30.
01.06.2001Elevated carbohydrate antigen 19-9 (CA 19-9) in patients with Echinococcus infection
01.06.2001Clinical chemistry and laboratory medicine : CCLM / FESCC 2001; 39:527-30
Pfister M, Gottstein B, Kretschmer R, Cerny Thomas
Taxanes in lung cancer: a review with focus on the European experience
Calderoni A, Cerny T. Taxanes in lung cancer: a review with focus on the European experience. Critical reviews in oncology/hematology 2001; 38:105-27.
01.05.2001Taxanes in lung cancer: a review with focus on the European experience
01.05.2001Critical reviews in oncology/hematology 2001; 38:105-27
Calderoni A, Cerny Thomas
Weekly x 4 induction therapy with the anti-CD20 antibody rituximab: effect on circulating t(14;18)(+) follicular lymphoma cells
Pichert G, Stahel R, Schmitter D, Stupp R, Betticher D, Cogliatti S, Cerny T, Hess U, Schmitz S, Ghielmini M. Weekly x 4 induction therapy with the anti-CD20 antibody rituximab: effect on circulating t(14;18)(+) follicular lymphoma cells. Clinical lymphoma 2001; 1:293-7.
01.03.2001Weekly x 4 induction therapy with the anti-CD20 antibody rituximab: effect on circulating t(14;18)(+) follicular lymphoma cells
01.03.2001Clinical lymphoma 2001; 1:293-7
Pichert G, Stahel R A, Schmitter D, Stupp R, Betticher D, Cogliatti S B, Cerny Thomas, Hess U, Schmitz S F, Ghielmini M
Attitudes and Beliefs towards Disease and Treatment in Patients with Advanced Cancer Using Anthroposophical Medicine
von Rohr E, Pampallona S, van Wegberg B, Cerny T, Hürny C, Bernhard J, Helwig S, Heusser P. Attitudes and Beliefs towards Disease and Treatment in Patients with Advanced Cancer Using Anthroposophical Medicine. Onkologie 2000; 23:558-563.
01.12.2000Attitudes and Beliefs towards Disease and Treatment in Patients with Advanced Cancer Using Anthroposophical Medicine
01.12.2000Onkologie 2000; 23:558-563
von Rohr E., Pampallona S., van Wegberg B., Cerny Thomas, Hürny C., Bernhard J., Helwig S., Heusser P.
Current Status of Dendritic Cell-Based Tumor Vaccination
Dannull J, Cerny T, Ackermann D, Groettrup M. Current Status of Dendritic Cell-Based Tumor Vaccination. Onkologie 2000; 23:544-551.
01.12.2000Current Status of Dendritic Cell-Based Tumor Vaccination
01.12.2000Onkologie 2000; 23:544-551
Dannull J., Cerny Thomas, Ackermann D.K., Groettrup M.
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer
Dannull J, Diener P, Prikler L, Fürstenberger G, Cerny T, Schmid U, Ackermann D, Groettrup M. Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer. Cancer research 2000; 60:5522-8.
01.10.2000Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer
01.10.2000Cancer research 2000; 60:5522-8
Dannull J, Diener P A, Prikler L, Fürstenberger G, Cerny Thomas, Schmid U, Ackermann D K, Groettrup M
Experiences in the realisation of a research project on anthroposophical medicine in patients with advanced cancer
Von Rohr E, Pampallona S, Van Wegberg B, Hürny C, Bernhard J, Heusser P, Cerny T. Experiences in the realisation of a research project on anthroposophical medicine in patients with advanced cancer. Schweizerische medizinische Wochenschrift 2000; 130:1173-84.
26.08.2000Experiences in the realisation of a research project on anthroposophical medicine in patients with advanced cancer
26.08.2000Schweizerische medizinische Wochenschrift 2000; 130:1173-84
Von Rohr E, Pampallona S, Van Wegberg B, Hürny C, Bernhard J, Heusser P, Cerny Thomas
Pneumococcal vaccine in patients with absent or dysfunctional spleen
Kobel D, Friedl A, Cerny T, Mühlemann K. Pneumococcal vaccine in patients with absent or dysfunctional spleen. Mayo Clinic proceedings. Mayo Clinic 2000; 75:749-53.
01.07.2000Pneumococcal vaccine in patients with absent or dysfunctional spleen
01.07.2000Mayo Clinic proceedings. Mayo Clinic 2000; 75:749-53
Kobel D E, Friedl A, Cerny Thomas, Mühlemann K
[Oncology 1999: advances in immunotherapy]
Cerny T. [Oncology 1999: advances in immunotherapy]. Schweizerische medizinische Wochenschrift 2000; 130:21-4.
11.01.2000[Oncology 1999: advances in immunotherapy]
11.01.2000Schweizerische medizinische Wochenschrift 2000; 130:21-4
Cerny Thomas
[Importance of lymph node involvement in breast carcinoma for the oncologist]
Cerny T. [Importance of lymph node involvement in breast carcinoma for the oncologist]. Zentralblatt für Chirurgie 2000; 125:813-6.
01.01.2000[Importance of lymph node involvement in breast carcinoma for the oncologist]
01.01.2000Zentralblatt für Chirurgie 2000; 125:813-6
Cerny Thomas
Role of high-dose therapy in diffuse large B-cell lymphoma
Cerny T, Betticher D. Role of high-dose therapy in diffuse large B-cell lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000; 11 Suppl 3:117-21.
01.01.2000Role of high-dose therapy in diffuse large B-cell lymphoma
01.01.2000Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000; 11 Suppl 3:117-21
Cerny Thomas, Betticher D
Pharmacokinetics of 2-chloro-2'-deoxyadenosine administered subcutaneously or by continuous intravenous infusion
Sonderegger T, Betticher D, Cerny T, Lauterburg B. Pharmacokinetics of 2-chloro-2'-deoxyadenosine administered subcutaneously or by continuous intravenous infusion. Cancer chemotherapy and pharmacology 2000; 46:40-2.
01.01.2000Pharmacokinetics of 2-chloro-2'-deoxyadenosine administered subcutaneously or by continuous intravenous infusion
01.01.2000Cancer chemotherapy and pharmacology 2000; 46:40-2
Sonderegger T, Betticher D C, Cerny Thomas, Lauterburg B H
Analgesic action of i.v. morphine-6-glucuronide in healthy volunteers
Buetler T, Wilder-Smith O, Wilder-Smith C, Aebi S, Cerny T, Brenneisen R. Analgesic action of i.v. morphine-6-glucuronide in healthy volunteers. British journal of anaesthesia 2000; 84:97-9.
01.01.2000Analgesic action of i.v. morphine-6-glucuronide in healthy volunteers
01.01.2000British journal of anaesthesia 2000; 84:97-9
Buetler T M, Wilder-Smith O H, Wilder-Smith C H, Aebi S, Cerny Thomas, Brenneisen R
The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK)
Ghielmini M, Bertoni F, Schmitter D, Lohri A, Wernli M, Stupp R, Betticher D, Pichert G, Bürki K, Schmitz S, Cerny T. The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000; 11 Suppl 1:123-6.
01.01.2000The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK)
01.01.2000Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000; 11 Suppl 1:123-6
Ghielmini M, Bertoni F, Schmitter D, Lohri A, Wernli M, Stupp R, Betticher D C, Pichert G, Bürki K, Schmitz S F, Cerny Thomas
Accelerated progression of multiple myeloma during anti-CD20 (Rituximab) therapy
Korte W, Jost C, Cogliatti S, Hess U, Cerny T. Accelerated progression of multiple myeloma during anti-CD20 (Rituximab) therapy. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999; 10:1249-50.
01.10.1999Accelerated progression of multiple myeloma during anti-CD20 (Rituximab) therapy
01.10.1999Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999; 10:1249-50
Korte W, Jost C, Cogliatti S, Hess U, Cerny Thomas
[Is there progress in the chemotherapy of small cell lung cancer?]
Calderoni A, Cerny T, Betticher D. [Is there progress in the chemotherapy of small cell lung cancer?]. Schweizerische medizinische Wochenschrift 1999; 129:1313-20.
18.09.1999[Is there progress in the chemotherapy of small cell lung cancer?]
18.09.1999Schweizerische medizinische Wochenschrift 1999; 129:1313-20
Calderoni A, Cerny Thomas, Betticher D C
Saturable metabolism of continuous high-dose ifosfamide with mesna and GM-CSF: a pharmacokinetic study in advanced sarcoma patients. Swiss Group for Clinical Cancer Research (SAKK)
Cerny T, Brunner J, Sessa C, Honegger P, Schmitz S, Schaad R, Küpfer A, von Briel T, Leyvraz S, Boddy A. Saturable metabolism of continuous high-dose ifosfamide with mesna and GM-CSF: a pharmacokinetic study in advanced sarcoma patients. Swiss Group for Clinical Cancer Research (SAKK). Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999; 10:1087-94.
01.09.1999Saturable metabolism of continuous high-dose ifosfamide with mesna and GM-CSF: a pharmacokinetic study in advanced sarcoma patients. Swiss Group for Clinical Cancer Research (SAKK)
01.09.1999Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999; 10:1087-94
Cerny Thomas, Brunner J, Sessa C, Honegger P, Schmitz S F, Schaad R, Küpfer A, von Briel T, Leyvraz S, Boddy A V
Relapse and subarachnoid dissemination of a pineal germinoma 14 years after radiation therapy
Von Rohr E, Gönner F, Schroth G, Cerny T. Relapse and subarachnoid dissemination of a pineal germinoma 14 years after radiation therapy. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 1999; 6:247-9.
01.05.1999Relapse and subarachnoid dissemination of a pineal germinoma 14 years after radiation therapy
01.05.1999Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 1999; 6:247-9
Von Rohr E, Gönner F, Schroth G, Cerny Thomas